(Q43001802)

12 November 2017

title

Management of chronic hepatitis C in childhood: the impact of therapy in the clinical practice during the first 2 decades (English)

1 reference

12 November 2017

Management of chronic hepatitis C in childhood: The impact of therapy in the clinical practice during the first 2 decades (English)

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

4 September 2024

1 reference

2

Giuseppe Indolfi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21111693

4 September 2024

author name string

Flavia Bortolotti

1

1 reference

12 November 2017

Lucia Zancan

3

1 reference

12 November 2017

Raffaella Giacchino

4

1 reference

12 November 2017

Gabriella Verucchi

5

1 reference

12 November 2017

Calogero Cammà

6

1 reference

12 November 2017

Cristiana Barbera

7

1 reference

12 November 2017

Massimo Resti

8

1 reference

12 November 2017

Maria Grazia Marazzi

9

1 reference

12 November 2017

Maria Guido

10

1 reference

12 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21111693

4 September 2024

publication date

15 December 2010

1 reference

full work available at URL

12 November 2017

https://api.elsevier.com/content/article/PII:S1590865810003282?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

https://api.elsevier.com/content/article/PII:S1590865810003282?httpAccept=text/plain

4 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Digestive and Liver Disease

4 September 2024

published in

1 reference

12 November 2017

volume

43

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

325-329

1 reference

Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children.

12 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Chronic hepatitis C in childhood: an 18-year experience.

4 September 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease

4 September 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome

4 September 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

The natural history of hepatitis C virus in pediatric liver transplant recipients

4 September 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Hepatitis C in children: a quaternary referral center perspective

4 September 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Clinical spectrum and histopathologic features of chronic hepatitis C infection in children

4 September 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

4 September 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

4 September 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Interferon treatment in children with chronic hepatitis C: long-lasting remission in responders, and risk for disease progression in non-responders

4 September 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

4 September 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics

4 September 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection

4 September 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

4 September 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Treatment of hepatitis C in children.

4 September 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999.

4 September 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period

4 September 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.

4 September 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Histological grading and staging of chronic hepatitis

4 September 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Low prevalence of anti-HCV antibody among Italian children.

4 September 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Intrafamilial transmission of hepatitis C virus: infection of the father predicts the risk of perinatal transmission

4 September 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period

4 September 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Managing pediatric hepatitis C: current and emerging treatment options

4 September 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy

4 September 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

Diagnosis, management, and treatment of hepatitis C: an update

4 September 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.DLD.2010.10.008

4 September 2024

Identifiers

1 reference

12 November 2017

1 reference